Literature DB >> 7826022

Biology and genetics of prion diseases.

S B Prusiner1.   

Abstract

Enriching fractions from Syrian hamster (SHa) brain for scrapie prion infectivity led to the discovery of the prion protein (PrP). Prion diseases include scrapie of sheep, bovine spongiform encephalopathy (BSE) of cattle, as well as Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease (GSS), and fatal familial insomnia (FFI) of humans. Discovery of mutations in the PrP genes of humans with familial CJD, GSS, and FFI established that prion diseases are both genetic and infectious. Many lines of evidence have converged to argue that infectious prions are composed largely, if not entirely, of PrPSc molecules. Mice overexpressing mutant and wild-type transgenes develop neurologic illnesses spontaneously and produce prions as demonstrated by serial transmission of disease in rodents after inoculation of brain extracts. Although these and many other findings argue that prions are devoid of nucleic acid, the molecular basis of prion strains remains enigmatic. The formation of PrPSc from PrPC is a posttranslational process involving the conversion of alpha-helices into beta-sheets. This conformational change in PrP appears to be the fundamental event that underlies prion propagation and the pathogenesis of prion diseases. The unique features of prion structure and propagation differentiate prions from all other transmissible pathogens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826022     DOI: 10.1146/annurev.mi.48.100194.003255

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  32 in total

1.  Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.

Authors:  R A Williamson; D Peretz; N Smorodinsky; R Bastidas; H Serban; I Mehlhorn; S J DeArmond; S B Prusiner; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Creutzfeldt-Jakob disease: the Canadian situation.

Authors:  E Stratton
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

3.  Inherited forms of Creutzfeldt-Jakob disease.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-04       Impact factor: 3.825

4.  Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.

Authors:  R Nakaoke; S Sakaguchi; R Atarashi; N Nishida; K Arima; K Shigematsu; S Katamine
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

Review 5.  More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change.

Authors:  Anupam K Chakravarty; Daniel F Jarosz
Journal:  J Mol Biol       Date:  2018-07-19       Impact factor: 5.469

6.  Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.

Authors:  Sandra Müller; Roland Kehm; Michaela Handermann; Nurith J Jakob; Udo Bahr; Björn Schröder; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  α-Synuclein Seeding Assay Using RT-QuIC.

Authors:  Ayami Okuzumi; Taku Hatano; Takeshi Fukuhara; Shinichi Ueno; Nobuyuki Nukina; Yuzuru Imai; Nobutaka Hattori
Journal:  Methods Mol Biol       Date:  2021

Review 8.  Protein-glycosaminoglycan interactions: infectiological aspects.

Authors:  D Sawitzky
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

9.  A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines.

Authors:  Daryl Rhys Jones; William Alexander Taylor; Clive Bate; Monique David; Mourad Tayebi
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

10.  Auxin-activated NADH oxidase activity of soybean plasma membranes is distinct from the constitutive plasma membrane NADH oxidase and exhibits prion-like properties.

Authors:  D James Morre; Dorothy M Morre; Philipp Ternes
Journal:  In Vitro Cell Dev Biol Plant       Date:  2003 Jul-Aug       Impact factor: 2.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.